Meto
Meto describes laboratory screening, quarterly consultations and ongoing messaging around compounded treatment. Its public terms still contain unfinished sections, and the treating practice and pharmacy are not identified.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
The proposed lab-and-follow-up structure is more specific than a simple prescription questionnaire. The unresolved clinical identities and unfinished contract deserve answers before payment. A matching system or a blood panel does not establish that a promoted treatment works.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Meto is a technology and care-coordination platform associated with Meto Health, Inc. It advertises compounded treatments and subscriptions rather than operating as a named medical practice or pharmacy. Its catalog includes semaglutide, tirzepatide, sermorelin, NAD+, glutathione and GHK-Cu, alongside experimental compounds that are outside the treatments compared here. Clinical decisions are assigned to independent clinicians. The public service describes a real consumer intake and payment process, but several material details need confirmation before enrolling.
What Meto prescribes, by goal
Weight
- SemaglutideFDA-approved
Listed by the seller; no price we hold.
- TirzepatideFDA-approved
Listed by the seller; no price we hold.
The GLP-1 page offers compounded semaglutide and tirzepatide and describes weekly subcutaneous use. It gives one family-level price rather than a clearly separated quote for each molecule and dose. The page also repeats generic nightly-injection and thirty-syringe kit language that does not clearly match a weekly prescription. Your clinician and pharmacy should resolve the actual product, instructions and quantity. Do not use the general page’s tutorial as an individual dosing plan.
Longevity
- NAD+Legal to compound
Listed by the seller; no price we hold.
- GlutathioneLegal to compound
Listed by the seller; no price we hold.
NAD+ and GHK-Cu are promoted for cellular function, repair and aging-related goals. NAD+ is a coenzyme rather than a peptide. Biological explanations and general research do not establish outcomes for the compounded product you would receive. GHK-Cu route and any combination ingredients also matter. Confirm the actual formulation and whether the intended use is supported before comparing the price or promised benefits.
Recovery
- SermorelinLegal to compound
Listed by the seller; no price we hold.
Sleep
- SermorelinLegal to compound
Listed by the seller; no price we hold.
Sermorelin appears as an individual protocol and within a muscle-preservation stack. The single protocol and stack have different prices and descriptions. Neither a lab match nor a claim about growth-hormone signaling demonstrates that every buyer will sleep better or preserve muscle. Ask what clinical concern is being treated, what monitoring will be used, and what evidence supports the exact preparation.
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
The current consumer pages describe licensed clinicians. The service does not name the medical practice or the clinician who would manage an individual prescription. Its clinician-recruitment page describes physicians and nurse practitioners signing treatment plans and handling messages. A clinician testimonial with an abbreviated name does not identify your treating provider. The service also describes licensed 503A pharmacies without naming a dispensing location. Ask for both the clinical practice and pharmacy, then verify the relevant licensing before paying for medication. A blog byline or an executive title should not substitute for those details.
The homepage starts with laboratory results, a medical intake and a clinician’s assessment. You can buy its $149 panel or submit recent results for review. The membership page describes fifteen-minute video check-ins every ninety days, weekly symptom logs, medical oversight and unlimited secure messages. It advertises a typical reply within twenty-four hours, not an immediate clinical response. Membership is said to begin when you approve the prescription rather than when the initial intake starts. The same-clinician claim appears on the about page, but the assigned person is not visible publicly. Ask how a request for more information or a need for in-person assessment affects the plan.
Are labs required?
Required assessment; panel paid separately
Laboratory screening is central to the advertised model, but buying a new panel is not presented as the only option: recent results can be uploaded. The panel is priced at $149 separately from membership and medication. The membership page says later redraws are discounted and can occur every three to six months, without publishing a universal repeat-test amount. It also uses broader quarterly-lab language. Ask which tests are required for your treatment, how often they will be repeated, and the actual additional bill. A test result alone is not a diagnosis or a guarantee of appropriate prescribing.
Ready to start with Meto?
Prices and plans are set on the seller's own site.
What it claims, and what it cites
Meto presents lab-based matching as personalized care and makes broad claims about recovery, tissue repair, metabolic health and longevity. Those claims do not establish that a particular protocol is appropriate or effective for a new patient. Its website acknowledges that compounded medication is not FDA-approved. Some catalog compounds and combinations need a separate regulatory and evidence assessment; a platform’s availability claim does not establish eligibility for routine use. The about page’s regulatory predictions should not be treated as current legal verification. The terms are also visibly unfinished: they describe some provisions as scaffolding and leave dispute resolution as a placeholder. That is a concrete reason to request the final contract.
Sold by Meto, not listed here
- BPC-157, TB-500, thymosin alpha-1, epitalon and mixed experimental stacks
- The site promotes these, but a public catalog listing does not establish their eligibility or product-specific evidence for the treatment comparisons here.
- Tesamorelin protocol
- The branded drug’s indication cannot establish the status or benefit of an unspecified compounded offering.
How it bills
The membership page lists $29 monthly for clinical services, with medication and a $149 initial panel billed separately. Some public protocol pages print specific medication amounts, but the catalog mixes individual products, combinations and general family-level quotes. That does not establish a complete individualized prescription bill. A complete quote needs the exact treatment and payment schedule. The terms say membership renews automatically until canceled from the account; ending it stops future renewals without refunding the current period unless law requires otherwise. Medication refund rules and a complete final contract remain unresolved.
For and against
- For: Lab results precede the proposed prescription
- For: Quarterly video visits described
- For: Unlimited secure messaging advertised
- For: Membership and medication separated publicly
- Against: Treating practice and pharmacy unnamed
- Against: Legal terms contain unfinished placeholders
- Against: Catalog combines unlike treatment packages
- Against: GLP-1 page instructions need clarification
The evidence behind what it sells
- Tirzepatide Headache: What the Labels and Trial Results Recorded
- Does NAD Cause Cancer? What Human and Animal Studies Show
- Sermorelin vs HGH: A Signal to the Pituitary or the Hormone Itself
- Does Tirzepatide Make You Tired? What the Trials and Labels Show
- NAC vs Glutathione: Which One Raises Glutathione in People?
- Does Sermorelin Work? What the Human Studies Measured
Right for
Someone interested in a lab-based clinical discussion who will obtain the final contract and verify the treating practice, pharmacy and prescription first.
Look elsewhere if
Someone seeking an established product-specific outcome, a fully resolved public contract, or a price that requires no clarification.
Other sellers for weight
50 Stars Health
Also prescribes Semaglutide, Tirzepatide.
Actin
Also prescribes Semaglutide, Tirzepatide.
AgelessRx
Also prescribes Semaglutide, Tirzepatide.
Meto
Frequently asked questions
- Is Meto itself the prescribing practice?
- No. The terms describe a technology platform connecting users with independent clinicians, laboratories and pharmacies. The current pages do not identify the assigned clinical practice or dispenser.
- Does buying the $149 panel guarantee treatment?
- No. The terms say that ordering laboratory work or a protocol does not guarantee a prescription. Recent outside results may also be submitted for review.
- Are Meto’s contract terms final?
- The public terms currently contain explicit scaffolding and placeholder language. Request the complete applicable agreement before authorizing payment.
Sources
- Lab-first entry and recent-test option
- Clinical membership, video review and test charges
- Platform role and unfinished legal terms
- Clinical model and continuity claims
- How the independent clinician network works
- Catalog of individual and mixed protocols
- GLP-1 product and instruction inconsistencies
See what Meto prescribes today
Meto sets its own prices, plans and the states it serves. Check them before you start.